This enduring education showcases two experts in treatment of generalized myasthenia gravis (gMG) discussing the rationale for C5-targeted therapies in gMG, individualize treatment for appropriate patients based on evidence, and formulate patient-centered strategies for optimizing integration as the therapeutic class expands.As a result of this educational curriculum, learners will be better able to: 1. Assess the rationale for C5-targeted therapies in patients with gMG; 2. Individualize C5-targeted therapy for appropriate patients with gMG based on available evidence; and, 3. Formulate patient-centered, evidence-based strategies for optimizing integration of C5-targeted therapies for gMG as they become available. Learners have access to downloadable materials.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- includes Online course / module
- Credit · Up to 0.5 credits
- Commercial Support
-
Available fromOct 23, 2026
-
Last day to claim creditOct 23, 2027 1 year left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Ready, Set, Complement! Novel C5 Inhibitors in Generalized Myasthenia Gravis
-
eMedEd Modern Strategies in Generalized Myasthenia Gravis: Diagnosis, Therapy, and Individualized Care
-
Global Learning Collaborative Practical Perspectives in MG #3: Therapeutic Selection and Monitoring Efficacy Matching Mechanisms to Patients
-
Answers in CME Inc. (AiCME) Complement Is Key: Exploring the Role of C5-Targeted Therapies in Generalized Myasthenia Gravis
-
Multiple Myeloma Research Foundation (MMRF) +1 Clinical Pearls for Subcutaneous Delivery: Optimizing Anti-CD38 Delivery in Multiple Myeloma
-
Answers in CME Inc. (AiCME) When Form Maximizes Function: Examining the Role of Subcutaneous Immune Checkpoint Inhibitors in Oncology Practice
